Skip to main content
G logo

G · Genpact LTD · Documents

Track G — free
Market Cap
$7.29B
Shares
167.23M
Volume · Nov 13 2.44M Avg daily vol (3M) 2.11M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $5.08B up 6.6% 10-K filed Feb 26, 2026 Quarterly report FY2026 Q3 Revenue $1.39B up 7.3% 10-Q filed Nov 6, 2026 Latest results Revenue growth drives higher full-year margin and EPS guidance 8-K filed Nov 5, 2026 Earnings call Q3 2026 earnings call Held Nov 5, 2026
2026
Nov 12
Current report 8-K Events of Nov 10
Shareholders approve move to Delaware

Genpact Limited shareholders approved changing its jurisdiction of incorporation from Bermuda to Delaware, discontinuing as an exempted company limited by shares and continuing as a Delaware corporation.

Shareholder vote results
Source passage
Company shareholders approved the change of the Company’s jurisdiction of incorporation from Bermuda to the State of Delaware by discontinuing as an exempted company limited by shares in Bermuda and continuing and domesticating as a corporation incorporated under the laws of the State of Delaware. Open the document at this passage
Nov 6
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rises 7.3% as Advanced Technology Solutions expands 30.3%

Genpact Limited reported third-quarter net revenues of $1,385.4 million, up 7.3%, as Advanced Technology Solutions revenue grew 30.3% to $405.1 million. Income from operations rose to $211.0 million and adjusted income from operations to $246.5 million.

Revenue $1.39B ▲ 7.3% Net income $151.66M ▲ 4.0% Diluted EPS $0.89 ▲ 7.2%
Read from the MD&A section
5 source passages
Our name after the Domestication will remain “Genpact Limited.” Our net revenues were $1,385.4 million in the third quarter of 2026, up $94.1 million, or 7.3%, from $1,291.3 million in the third quarter of 2025. Net revenues from Advanced Technology Solutions in the third quarter of 2026 were $405.1 million, up $94.1 million, or 30.3%, from $311.0 million in the third quarter of 2025. Income from operations was $211.0 million in the third quarter of 2026, up $19.3 million from $191.6 million in the third quarter of 2025. adjusted income from operations (“AOI”) increased by $17.6 million to $246.5 million in the third quarter of 2026 from $228.9 million in the third quarter of 2025. Open the document at this passage
Nov 5
Earnings call
Revenue rises 7.3%; agentic bookings expected above $1 billion

Genpact reported Q3 revenue growth of 7.3% year-over-year and expects agentic bookings to exceed $1 billion by year-end 2026. Advanced technology solutions revenue grew 30.3%, and full-year revenue growth is expected to be at least 7%.

4 source passages
We delivered $1.385 billion in total revenue for the third quarter. This 7.3% year-over-year total revenue growth was delivered despite roughly two points of impact from our transition away from work not aligned with our agentic operation strategy. At the same time, advanced technology solutions revenue, which includes data and AI, digital technologies, advisory, and agent tech, reached $405 million this quarter, growing 30.3% year over year. Last quarter, I said we are on track to exceed $1 billion. In agentic solutions booking for 2026, our momentum has only strengthened. Now, I am pleased to report that we will exceed that number by a margin. For the full year 2026, we expect at least 7% revenue growth on an as-reported basis, given our strong backlog, pipeline, and ability to execute. Open the document at this passage
Nov 5
Current report 8-K
Revenue growth drives higher full-year margin and EPS guidance

Genpact reported third-quarter net revenues of $1.385 billion, up 7.3% year-over-year, and raised 2026 gross-margin guidance to approximately 36.9% and adjusted diluted EPS growth guidance to at least 13%.

Financial results
4 source passages
Net revenues were $1.385 billion, up 7.3% year-over-year, and 7.5% on a constant currency basis.2 Genpact's updated outlook for the full year 2026 is as follows: Gross margin outlook increased to approximately 36.9%, up approximately 90 basis points year-over-year. Adjusted diluted earnings per share5 growth increased to at least 13% year-over-year. Open the document at this passage
Oct 5
Registration statement S-4/A
Registration statement

Genpact Limited will seek shareholder approval on November 10, 2026 to move incorporation from Bermuda to Delaware, expected on or around March 1, 2027; common shares will convert into an equivalent number of Delaware common stock.

Read from the first part of this long document
Aug 7
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $1.34B ▲ 7.1% Net income $145.74M ▲ 9.8% Diluted EPS $0.86 ▲ 14.7%
May 8
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $1.3B ▲ 6.7% Net income $147.99M ▲ 13.1% Diluted EPS $0.86 ▲ 17.8%
Mar 11
Proxy statement DEF 14A Meeting Apr 23, 2026
Proxy statement AI summary on its way
Feb 26
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $5.08B ▲ 6.6% Net income $552.49M ▲ 7.6% Diluted EPS $3.13 ▲ 9.8%
2025
Nov 7
Quarterly report 10-Q FY2025 Q3, ended Sep 30
Quarterly report for FY2025 Q3
Revenue $1.29B ▲ 6.6% Net income $145.83M ▲ 9.8% Diluted EPS $0.83 ▲ 12.2%
Aug 11
Quarterly report 10-Q FY2025 Q2, ended Jun 30
Quarterly report for FY2025 Q2
Revenue $1.25B ▲ 6.6% Net income $132.72M ▲ 8.8% Diluted EPS $0.75 ▲ 11.9%
May 12
Quarterly report 10-Q FY2025 Q1, ended Mar 31
Quarterly report for FY2025 Q1
Revenue $1.21B ▲ 7.4% Net income $130.85M ▲ 11.9% Diluted EPS $0.73 ▲ 14.1%
Mar 3
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $4.77B ▲ 6.5% Net income $513.67M ▼ 18.6% Diluted EPS $2.85 ▼ 16.4%
2024
Nov 12
Quarterly report 10-Q FY2024 Q3, ended Sep 30
Quarterly report for FY2024 Q3
Revenue $1.21B ▲ 6.6% Net income $132.82M ▲ 12.9% Diluted EPS $0.74 ▲ 15.6%
Aug 9
Quarterly report 10-Q FY2024 Q2, ended Jun 30
Quarterly report for FY2024 Q2
Revenue $1.18B ▲ 6.4% Net income $121.99M ▲ 4.9% Diluted EPS $0.67 ▲ 6.3%
Showing 1–50 of 135 documents
Key facts CIK 1398659 CUSIP G3922B107 13F (30d) 403 filings 362 filers Visit website Investor relations